-- 第一資本房地產投資信託基金(First Capital Real Estate Investment Trust,股票代碼:FCR-UN.TO)週二收盤後公佈,受創紀錄的入住率和強勁的續租價差推動,其第一季淨利潤同比增長9.2%。 截至3月31日的三個月內,該房地產投資信託基金歸屬於單位持有人的淨利潤為9,220萬美元,即每單位0.43美元,而去年同期為8,440萬美元,即每單位0.39美元。 該公司每單位營運資金(FFO)為0.35美元,年增7.6%。此外,其投資組合總入住率為97.2%,較去年同期成長30個基點。 「我們很高興地宣布,本季營運和財務業績依然強勁,其中入住率創歷史新高,同店淨營業收入(NOI)穩步增長,續租價差也十分可觀,這些都推動了每單位營運資金(FFO)的強勁增長,」首席執行官亞當·保羅表示。 “我由衷地感謝並為FCR團隊感到自豪。我們共同努力,通過嚴格執行既定戰略,取得了持續優異的業績。”保羅繼續說道,“這一基礎為FCR的成功奠定了基礎,並最終促成了上個月宣布的以創紀錄的單位價格被收購的協議。” 該房地產投資信託基金(REIT)的單位在多倫多證券交易所收盤上漲0.12美元,至23.48美元。
Related Articles
Simcere Pharmaceutical Receives Chinese Regulatory Approval to Begin Trials of Tumor Drug
Simcere Pharmaceutical (HKG:2096) received Chinese regulatory approval to begin clinical trials of SIM0613, according to a Hong Kong bourse filing Wednesday.The injection is intended to treat advanced solid tumors and is licensed to Ipsen Pharma in regions outside Greater China.
Meitu Records 30% Rise in Paying Subscribers
Meitu (HKG:1357) said the number of paying subscribers using its platform grew 30% year on year to 17.90 million as of end March, according to a Hong Kong bourse filing Wednesday.Paying subscribers for the company's productivity tools grew 53% to 2.34 million, while leisure app subscribers increased 27% to 15.56 million, the firm said.The company's core revenue grew 34.3% year on year to 852 million yuan, while other businesses remained "stable overall."The company's annual recurring revenue for AI-driven productivity apps stood at 580 million yuan as of March, a 56% increase from a year earlier.
Yidu Tech Unit Wins SG$2.3 Million Singapore Healthcare Project
Yidu Tech (HKG:2158) said its subsidiary EVYD Research Private Limited won a contract from Singapore Health Services for the implementation and support of Dr Buddy, according to a Wednesday Hong Kong bourse filing.The total project amount is about SG$2.3 million.